# Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases

> **NCT02349399** · — · COMPLETED · sponsor: **Bayer** · enrollment: 26065 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Cyproterone / Ethinylestradiol (Diane-35, BAY86-5264) and its Generics

## Key facts

- **NCT ID:** NCT02349399
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-01
- **Primary completion:** 2016-03-01
- **Final completion:** 2016-03-01
- **Target enrollment:** 26065 (ACTUAL)
- **Last updated:** 2017-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02349399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02349399, "Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02349399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*